Table 1 Clinical characteristics of patients with hypergammaglobulinemia
Total | Autoimmune | Infection | Malignancy | PID | Drug | Other | |
|---|---|---|---|---|---|---|---|
n = 442 | n = 221 | n = 163 | n = 10 | n = 15 | n = 9 | n = 25 | |
Median age, years | 14.3 | 13.8 | 14.8 | 13.2 | 13.7 | 16.6 | 13.8 |
Female, n (%) | 228 (63) | 168 (76) | 80 (49) | 2 (20) | 11 (73) | 5 (56) | 12 (48) |
Race/ethnicity, n (%) | |||||||
White | 229 (52) | 95 (43) | 107 (66) | 5 (50) | 6 (40) | 8 (89) | 8 (32) |
Black | 81 (18) | 49 (22) | 24 (15) | 2 (20) | 0 (0) | 0 (0) | 7 (28) |
Hispanic | 31 (7) | 19 (9) | 9 (6) | 1 (10) | 0 (0) | 0 (0) | 2 (8) |
Asian | 26 (6) | 13 (6) | 6 (4) | 1 (10) | 3 (20) | 0 (0) | 3 (12) |
Other/unknown | 75 (17) | 44 (20) | 17 (10.6) | 2 (20) | 6 (40) | 1 (17) | 5 (20) |
Median follow-up period, years | 2.9 | 3.3 | 3.0 | 3.5 | 2.6 | 0.5 | 2.0 |
Death during follow-up period, n (%) | 42 (10) | 6 (3) | 30 (18) | 3 (30) | 1 (7) | 0 (0) | 1 (4) |